‘Next generation’ chromium shows superior insulin management
date:Jun 13, 2012
lin management ingredient available.

Study details

For the new randomized, double-blind, placebo-controlled study, researchers led by Dr Sushil Jain from Louisiana State University Health Sciences Center recruited 74 type-2 diabetics and randomly assigned them to receive placebo, Zychrome (400 micrograms of elemental chromium) or chromium picolinate (400 micrograms of elemental chromium) daily.

Results of the three month study indicated that the chromium dinicocysteinate group displayed signi
5/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/17 04:44